Impact of prior chemotherapy (CT) and somatostatin analogues (SSAs) on clinical outcome in well differentiated pancreatic neuroendocrine tumors (pWDNETs) before treatment with Everolimus (EV)
EUROPEAN JOURNAL OF CANCER（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要